AstraZeneca has signed a collaboration deal with VaxEquity, a spin-off of Imperial College London, for discovering, developing, and commercializing the latter’s self-amplifying RNA (saRNA) therapeutics platform. The long-term research collaboration is aimed at optimizing and validating the saRNA platform of VaxEquity to use it for advancing novel therapeutic programs. AstraZeneca will support the Imperial College […]
Imperial College London said that it has dosed the first healthy volunteer with its COVAC1 coronavirus vaccine candidate, which has been developed using the new self-amplifying RNA (saRNA) technology. The university claimed that the COVID-19 vaccine candidate has gone through rigorous pre-clinical safety tests, and in animal studies, it has been demonstrated to be safe, […]
The UK’s Medical Research Council has granted £5 million collectively to the University of Liverpool, the Imperial College London, and the University of Edinburgh to handle the coronavirus outbreak from the government’s rapid response call. This investment in Urgent Public Health Research is necessary to understand COVID-19 as well as its impact on the human […]